As I indicated last week, I wanted to write about a specific dialog that occurred at the December 4, 2012 California Board of Pharmacy Enforcement Committee meeting. The important exchange came at the end of the meeting during the catchall agenda item called “General Discussions” when topics that are not on the agenda can be raised by Board members or the general public in attendance.
I received very sad news last night of the loss of another friend and co-worker in the serialization and track and trace industry. Bob Bergantino, most recently of Excellis Health Solutions, worked for SupplyScape at the same time I did. We didn’t work on any projects or sales together but Bob was such a cheerful and inviting person that I couldn’t help but know and love him. Bob had a magnetic personality and was full of wit, charm and love for everyone around him. We will all miss him. Continue reading Robert J. “Bob” Bergantino (1960-2012)→
Last week I attended the Enforcement Committee meeting of the California Board of Pharmacy. The value of attending these meetings is hard to extract. It helps to have a solid knowledge of the language of the pedigree law, understanding of the standards and technology being considered to meet it, and the history of how we got where we are today. Even with all that on your side it takes a lot of concentration during the meeting and after it is over to put it all into perspective and find the value.
…a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance
DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of RxTrace. The material contained in RxTrace is not legal advice. The writers of RxTrace are not lawyers. The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating the positions of any company, organization or individual other than RxTrace.